Records 1 - 19
| Aberrant APOBEC3C expression induces characteristic genomic instability in pancreatic ductal adenocarcinoma.
Oncogenesis 2022 Jun 11 (1): 35.
Qian Yunzhen, Gong Yitao, Zou Xuan, Liu Yu, Chen Yusheng, Wang Ruijie, Dai Zhengjie, Tasiheng Yesiboli, Lin Xuan, Wang Xu, Luo Guopei, Yu Xianjun, Cheng He, Liu Ch
| Comprehensive analysis of tumor mutation burden and immune microenvironment in prostate cancer.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2022 Jun .
Liao Junqun, Ye Yuan, Xu Xur
| A special prognostic indicator: tumor mutation burden combined with immune infiltrates in lung adenocarcinoma with TP53 mutation.
Translational cancer research 2022 2 10 (9): 3963-3978.
Fu Jing, Li Yaonan, Li Cuidan, Tong Yuyang, Li Mengyuan, Cang Shundo
| Integrative Multiomics Evaluation of IIDH1 Metabolic Enzyme as a Candidate Oncogene That is Correlated with Poor Prognosis and Immune Infiltration in Prostate Adenocarcinoma.
Journal of oncology 2022 2022 9854788.
Wen Chen-Yueh, Tsui Kuan-Hao, Chang Chiung-Hung, Chiu Yi-Han, Lin Shu-Chuan Amy, Chu Ching-Yu, Li Chia-Ju
| Mutation of MUC16 Is Associated With Tumor Mutational Burden and Lymph Node Metastasis in Patients With Gastric Cancer.
Frontiers in medicine 2022 9 836892.
Zhang Fengxiang, Li Xianzhe, Chen Huaxian, Guo Jianping, Xiong Zhizhong, Yin Shi, Jin Longyang, Chen Xijie, Luo Dandong, Tang Haijie, Mao Chaobin, Lian L
| Systemic immune microenvironment and regulatory network analysis in patients with lung adenocarcinoma.
Translational cancer research 2022 2 10 (6): 2859-2872.
Liu Libao, Xu Shilei, Huang Lei, He Jinyuan, Liu Gang, Ma Shaohong, Weng Yimin, Huang Shaoho
| The Oncogenic and Immunological Roles of Apoptosis Antagonistic Transcription Factors in Human Tumors: A Pan-Cancer Analysis.
Oxidative medicine and cellular longevity 2022 10 2022 3355365.
Lu Feng, Wu Juan, Zou Hongpeng, Yang Xin, Wu Yongbing, Xu Jianj
| Lung adenocarcinoma patients with KEAP1 mutation harboring low immune cell infiltration and low activity of immune environment.
Thoracic cancer 2021 Jul .
Cheng Wanwan, Xu Bin, Zhang Haitao, Fang Shenc
| A risk model developed based on tumor microenvironment predicts overall survival and associates with tumor immunity of patients with lung adenocarcinoma.
Oncogene 2021 Jun .
Wu Jie, Li Lan, Zhang Huibo, Zhao Yaqi, Zhang Haohan, Wu Siyi, Xu B
| Less immune cell infiltration and worse prognosis after immunotherapy for patients with lung adenocarcinoma who harbored STK11 mutation.
International immunopharmacology 2020 May 84 106574.
Wang Haiyong, Guo Jun, Shang Xiaoling, Wang Zheh
| Comparative bioinformatical analysis of pancreatic head cancer and pancreatic body/tail cancer.
Medical oncology (Northwood, London, England) 2020 Apr 37 (5): 46.
Yin Lingdi, Xiao Linmei, Gao Yong, Wang Guangfu, Gao Hao, Peng Yunpeng, Zhu Xiaole, Wei Jishu, Miao Yi, Jiang Kuirong, Lu Zipe
| Molecular and immune characteristics for lung adenocarcinoma patients with CMTM6 overexpression.
International immunopharmacology 2020 Apr 83 106478.
Wang Hui, Gao Jinping, Zhang Renfeng, Li Meng, Peng Zhongmin, Wang Haiyo
| Comparison of therapeutic effects of EGFR-tyrosine kinase inhibitors on 19Del and L858R mutations in advanced lung adenocarcinoma and effect on cellular immune function.
Thoracic cancer 2017 Dec .
Zhou Juan, Ben Suq
| Low PD-1 Expression in Cytotoxic CD8 Tumor-Infiltrating Lymphocytes Confers an Immune-Privileged Tissue Microenvironment in NSCLC with a Prognostic and Predictive Value.
Clinical cancer research : an official journal of the American Association for Cancer Research 2017 Oct .
Mazzaschi Giulia, Madeddu Denise, Falco Angela, Bocchialini Giovanni, Goldoni Matteo, Sogni Francesco, Armani Giovanna, Lagrasta Costanza Annamaria, Lorusso Bruno, Mangiaracina Chiara Maria, Vilella Rocchina, Frati Caterina, Alfieri Roberta R, Ampollini Luca, Veneziani Michele, Silini Enrico M, Ardizzoni Andrea, Urbanek Konrad, Aversa Franco, Quaini Federico, Tiseo Marcel
| EGFR and KRAS mutation status in non-small-cell lung cancer occurring in HIV-infected patients.
Lung cancer (Amsterdam, Netherlands) 2016 Jun 96 74-7.
Créquit Perrine, Ruppert Anne-Marie, Rozensztajn Nathalie, Gounant Valérie, Vieira T, Poulot Virginie, Antoine Martine, Chouaid Christos, Wislez Marie, Cadranel Jacques, Lavole Armel
| A multi-institutional study of clinicopathological features and molecular epidemiology of epidermal growth factor receptor mutations in lung cancer patients living with human immunodeficiency virus infection.
Journal of cancer research and clinical oncology 2015 Sep 141 (9): 1669-78.
Okuma Yusuke, Tanuma Junko, Kamiryo Hiroshi, Kojima Yuki, Yotsumoto Mihoko, Ajisawa Atsushi, Uehira Tomoko, Nagai Hirokazu, Takeda Yuichiro, Setoguchi Yasuhiro, Okada Sei
| Phosphorylated alpha-enolase induces autoantibodies in HLA-DR8 pancreatic cancer patients and triggers HLA-DR8 restricted T-cell activation.
Immunology letters 2015 Sep 167 (1): 11-6.
Capello Michela, Caorsi Cristiana, Bogantes Hernandez Pablo Josè, Dametto Ennia, Bertinetto Francesca Eleonora, Magistroni Paola, Rendine Sabina, Amoroso Antonio, Novelli Frances
| Beyond GWAS in COPD: probing the landscape between gene-set associations, genome-wide associations and protein-protein interaction networks.
Human heredity 2014 78 (3-4): 131-9.
McDonald Merry-Lynn Noelle, Mattheisen Manuel, Cho Michael H, Liu Yang-Yu, Harshfield Benjamin, Hersh Craig P, Bakke Per, Gulsvik Amund, Lange Christoph, Beaty Terri H, Silverman Edwin K,
| Prognostic and Immunological Role of FAT Family Genes in Non-Small Cell Lung Cancer.
Cancer control : journal of the Moffitt Cancer Center 0 29 10732748221076682.
Feng Zhenxing, Yin Yan, Liu Bin, Zheng Yafang, Shi Dongsheng, Zhang Hong, Qin Jianw